Citadel Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $334K | Buy |
|
|||||
|
2024
Q4 | $369K | Sell |
|
|||||
|
2024
Q3 | $9.04M | Hold |
|
|||||
|
2024
Q2 | $8.62M | Buy |
|
|||||
|
2024
Q1 | $2.98M | Sell |
|
|||||
|
2023
Q4 | $3.18M | Hold |
|
|||||
|
2023
Q3 | $3.35M | Sell |
|
|||||
|
2023
Q2 | $5.58M | Buy |
|
|||||
|
2023
Q1 | $2.01M | Buy |
|
|||||
|
2022
Q4 | $4.25M | Buy |
|
|||||
|
2022
Q3 | $3.86M | Buy |
|
|||||
|
2022
Q2 | $1.82M | Sell |
|
|||||
|
2022
Q1 | $5.44M | Buy |
|
|||||
|
2021
Q4 | $2.45M | Buy |
|
|||||
|
2021
Q3 | $1.71M | Sell |
|
|||||
|
2021
Q2 | $1.97M | Buy |
|
|||||
|
2021
Q1 | $2.09M | Buy |
|
|||||
|
2020
Q4 | $524K | Sell |
|
|||||
|
2020
Q3 | $4.81M | Sell |
|
|||||
|
2020
Q2 | $11.5M | Buy |
|
|||||
|
2020
Q1 | $8.49M | Buy |
|
|||||
|
2019
Q4 | $4.81M | Buy |
|
|||||
|
2019
Q3 | $2.76M | Buy |
|
|||||
|
2019
Q2 | $4.01M | Sell |
|
|||||
|
2019
Q1 | $10.2M | Sell |
|
|||||
|
2018
Q4 | $17.3M | Buy |
|
|||||
|
2018
Q3 | $4.77M | Sell |
|
|||||
|
2018
Q2 | $20.7M | Buy |
|
|||||
|
2018
Q1 | $222K | Sell |
|
|||||
|
2017
Q4 | $1.73M | Sell |
|
|||||
|
2017
Q3 | $2.85M | Sell |
|
|||||
|
2017
Q2 | $2.49M | Buy |
|
|||||
|
2017
Q1 | $1.28M | Buy |
|
|||||
|
2016
Q4 | $137K | Sell |
|
|||||
|
2016
Q3 | $261K | Buy |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Hold |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $136K | Sell |
|
|||||
|
2015
Q1 | $455K | Buy |
|
|||||
|
2014
Q4 | $75K | Sell |
|
|||||
|
2014
Q3 | $4.55M | Buy |
|
|||||
|
2014
Q2 | $1.75M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $546K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $1.41M | Buy |
|